April 18, 2024 News by Marisa Wexler, MS AAN 2024: Sustained myelin, nerve cell gains with long-term CNM-Au8 Long-term treatment with Clene Nanomedicine‘s experimental oral therapy CNM-Au8 led to signs of sustained improvements in nerve and myelin health for people with relapsing-remitting multiple sclerosis (RRMS) over three years, according to new data from the VISIONARY-MS clinical trial. The findings continue to support Clene’s plans to…
December 13, 2023 News by Marisa Wexler, MS Novel compound ZCAN262 restores lost myelin in MS mouse models A novel compound that can lessen toxic overactivation of nerve cells was found to significantly reduce disease activity and restore lost myelin in two mouse models of multiple sclerosis (MS), a new study reports. Researchers say the compound, ZCAN262, may be a potential new treatment for MS should future…
May 3, 2023 News by Lindsey Shapiro, PhD Antibody clumps in blood could drive nerve cell death in MS Clusters of immunoglobulin G (IgG) antibodies in theĀ blood of multiple sclerosis (MS) patients appear to contribute to the nerve cell death that marks the neurodegenerative disease, according to a recent study. IgG antibodies harvested from the blood of MS patients drove nerve cell death in cell cultures, whereas antibodies…
December 8, 2022 News by Margarida Maia, PhD New Patent Filed for EmtinB With Copaxone as Potential MS Therapy NeuroScientific Biopharmaceuticals has filed a patent in Australia to protect the use of its lead candidate EmtinB in combination with Tevaās Copaxone (glatiramer acetate injection) as a potential treatment for multiple sclerosis (MS). The patent application (provisional number 2022903564) is based on data from a lab…
February 16, 2022 News by Lindsey Shapiro, PhD UK MS Society Investing $1.5M in Support of 9 Research Projects The MS SocietyĀ of the U.K. intends to raise over Ā£1.1 million (about $1.5 million) to support nineĀ multiple sclerosis (MS) research projects, marking the return of the grants program it put on hold due to the COVID-19 pandemic. Funding will support research in the…
March 30, 2020 News by Marta Figueiredo, PhD Way of Getting Nerve Cells to Restore Myelin-like Abilities Seen as Possible Researchers developed a way of reprograming cells to use synthetic materials ā provided by the team ā to create artificial, working structures within or about the cells. This approach may be a way to reprogram nerve cells to produce myelin-like protective polymers ā large molecules made of many repeating…
August 14, 2018 News by Ana Pena PhD Detailed Map of Mouse Nervous System May Help Uncover Origin of Neurological Diseases, Including MS Researchers have created a detailed map of the mouse nervous system, including the location of the many diverse cell types in the brain, in the largest study yet of the makeup of the mammalian nervous system.Ā The new map could provide new clues about the origin of neurological…
April 3, 2017 News by Patricia Inacio, PhD Scientists Accelerate Stem Cells’ Production of Brain Cells to Just Days, Study Reports British scientists have accelerated from weeks to days the process by which stem cells generate brain cells, which could open the door to new treatment approaches for diseases such as multiple sclerosis. Researchers at the Wellcome Trust Sanger Institute and colleagues at the University of Cambridge developed the…